SEC Form 4 · accession 0001209191-18-005091
GLOBUS MEDICAL INC · GMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel T Scavilla
Officer — Senior VP and CFO
Period of report
Jan 22, 2018
Accepted (ET)
Jan 24, 2018 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001237831
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F1 | $43.77 | Jan 22, 2018 | A | 80,000 | A | — | Jan 22, 2028 | Class A Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.